Meihua Holdings Group Co.Ltd(600873) 3 on the evening of March 13, the annual report of 2021 was released. The company achieved an operating revenue of 22.837 billion yuan in 2021, with a year-on-year increase of 33.94%; The net profit attributable to the shareholders of the listed company was 2.351 billion yuan, a year-on-year increase of 139.40%; The basic earnings per share is 0.76 yuan. The company plans to distribute cash dividends of 4 yuan (including tax) to all shareholders for every 10 shares.
The annual report shows that in 2021, although the prices of main raw materials increased to varying degrees, the company continued to improve its operation and management level, make scientific decisions, seize the favorable opportunity of the market, and rely on the advantages of scale, multiple products and cost, the main products are monosodium glutamate, threonine, lysine The price increase of xanthan gum and other feed amino acid products was greater than that of raw materials, and the overall profitability of the company’s main products was further improved. During the reporting period, the sales price of lysine increased by 37.63% year-on-year, and the sales price of threonine increased by 44.75% year-on-year compared with 2020.
Looking forward to 2022, the company said that in 2022, the company will strive to continue to realize the continuous growth of sales revenue and profit. While expanding the scale, the company will continue to promote and deepen the construction of management system and talent system, continue to take budget as the starting point of management, take performance appraisal as the main tool to improve management, and promote the construction of standardized management system, Comprehensively build a human resources management system.
